&nbsp;

Updated

Nov 2025

Guidelines and Advice

Preoperative Breast Magnetic Resonance Imaging

Status: Current
ID: GL 1-25
Version: N/A

Mar 2023

Drug

ivosidenib

Other Name(s): Tibsovo®

Quick Link(s):

Nov 2025

Regimen

MIRV

Cancer Type:

Gynecologic,

Ovary

, Collapse Show fewer tags

Intent: Palliative

Drugs Used:

mirvetuximab soravtansine (Compassionate)

... Show more tags

Quick Link(s):

Regimen Monograph

Nov 2025

Guidelines and Advice

Cancer Care Ontario Thyroid Cancer Guideline: An Endorsement of the 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer

Status: Current
ID: GL END 5-13
Version: N/A

Jun 2023

Guidelines and Advice

The Role of Endolaryngeal Surgery (With or Without Laser) versus Radiotherapy in the Management of Early (T1) Glottic Cancer

Status: Current
ID: 5-2
Version: 2

Oct 2023

Drug

alectinib

Other Name(s): Alecensaro®

Quick Link(s):

Nov 2025

Regimen

CYTA(HD); MPV+RITU

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's High Grade

Intent: Curative

Funding:

ODB - General Benefit

procarbazine

, Collapse Show fewer tags

Drugs Used:

riTUXimab (Unfunded),

Quick Link(s):

Regimen Monograph

Nov 2025

Regimen

ALEC

Cancer Type:

Lung,

Non-Small Cell

Intent: Adjuvant

Funding:

Exceptional Access Program

alectinib - Adjuvant treatment of ALK-positive non-small cell lung cancer, according to specific criteria

, Collapse Show fewer tags

Drugs Used:

alectinib

... Show more tags

Quick Link(s):

Regimen Monograph

Nov 2025

Drug

ipilimumab

Other Name(s): Yervoy®

Quick Link(s):

Updated

Dec 2025

Drug

nivolumab

Other Name(s): Opdivo®

Quick Link(s):

Updated

Dec 2025

Drug

ripretinib

Other Name(s): Qinlock™

Quick Link(s):